There are 2934 resources available
7183 - Pan-cancer whole genome analyses of metastatic solid tumors
Presenter: Edwin Cuppen
Session: Proffered Paper session: Genomic characterization of cancer cells to guide precision medicine: Next steps
Resources:
Abstract
Slides
Webcast
7182 - Drug Rediscovery Protocol: Expanded use of existing anticancer drugs
Presenter: Emile Voest
Session: Proffered Paper session: Genomic characterization of cancer cells to guide precision medicine: Next steps
Resources:
Abstract
Slides
Proffered Paper session: Genomic characterization of cancer cells to guide precision medicine: Next steps - Invited Discussant LBA26 and LBA27
Presenter: Ruth Plummer
Session: Proffered Paper session: Genomic characterization of cancer cells to guide precision medicine: Next steps
Resources:
Slides
Webcast
Ranking genomic alterations for precision medicine: New developments of ESCAT
Presenter: Joaquin Mateo
Session: Proffered Paper session: Genomic characterization of cancer cells to guide precision medicine: Next steps
Resources:
Slides
Webcast
4795 - Trastuzumab and tucatinib for the treatment of HER2 amplified metastatic colorectal cancer (mCRC): Initial results from the MOUNTAINEER trial
Presenter: John Strickler
Session: Poster Discussion – Gastrointestinal tumours, colorectal
Resources:
Abstract
2951 - Impact of clonality and DNA repair mutations on plasma tumor mutation burden (pTMB) and immunotherapy efficacy in microsatellite stable (MSS) metastatic colorectal cancer (mCRC) in CCTG CO.26
Presenter: Jonathan Loree
Session: Poster Discussion – Gastrointestinal tumours, colorectal
Resources:
Abstract
1057 - TRIUMPH: Primary Efficacy of a Phase II Trial of Trastuzumab (T) and Pertuzumab (P) in Patients (pts) with Metastatic Colorectal Cancer (mCRC) with HER2 (ERBB2) Amplification (amp) in Tumor Tissue or Circulating Tumor DNA (ctDNA): A GOZILA Sub-study
Presenter: Yoshiaki Nakamura
Session: Poster Discussion – Gastrointestinal tumours, colorectal
Resources:
Abstract
3298 - Early identification of treatment effect by methylated circulating tumor DNA in metastatic colorectal cancer
Presenter: Caroline Thomsen
Session: Poster Discussion – Gastrointestinal tumours, colorectal
Resources:
Abstract
2646 - Sequential RAS mutation testing in cfDNA in RAS wild type (wt) metastatic colorectal cancer (mCRC) patients (pt) treated with panitumumab (P) and chemotherapy (CT) in first line (1L). PERSEIDA study
Presenter: Manuel Valladares-Ayerbes
Session: Poster Discussion – Gastrointestinal tumours, colorectal
Resources:
Abstract
5828 - Pre-operative FOLFOX chemotherapy in advanced colon cancer: pathology analysis of the FOxTROT trial
Presenter: Nick West
Session: Poster Discussion – Gastrointestinal tumours, colorectal
Resources:
Abstract